PHAT vs SMFG
Phathom Pharmaceuticals Inc (PHAT) versus SMFG (SMFG) — a side-by-side from cached financials, not a winner call.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
SMFG (SMFG) common stock.
Latest reported PHAT revenue for 2026-06-30 was $132.6M. Net income was -$48.0M. PHAT currently screens at market cap $622.7M.
SMFG does not have a complete income-statement cache yet.
PHAT currently screens at market cap $622.7M. SMFG currently screens at market cap $0.
Not investment advice. Open the PHAT and SMFG stock pages for the full models.
Not investment advice.